Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
Former journal editor had potential conflicts of interest in nine of 10 articles he authored
http://www.bmj.com/content/349/bmj.g7589[font face=Serif][font size=5]Former journal editor had potential conflicts of interest in nine of 10 articles he authored[/font]
BMJ 2014; 349 doi: http://dx.doi.org/10.1136/bmj.g7589 (Published 09 December 2014)
Cite this as: BMJ 2014;349:g7589
Owen Dyer
[font size=3]The former editor of the Journal of Patient Safety, who resigned after a US government lawsuit alleged that he had accepted substantial payments to influence national safety guidelines, also had potential conflicts of interest in nine of 10 articles he authored in his journal, a review published by the new editors has said.
Charles Denham was named in a legal settlement last December between the government and CareFusion, producer of the antiseptic skin formulation ChloraPrep. The government alleged that his company, Health Care Concepts, received $11.6m (£7.4m; €9.4m) in contracts from CareFusion and its legal predecessor Cardinal Health.1
“The United States contends that the compensation for the underlying services in these agreements was not fair market value,” the suit alleged, “and one purpose of these contracts was to conceal kickbacks to Dr Charles Denham.”
Denham was then serving as co-chair of the National Quality Forum’s Safe Practices Committee, whose safety recommendations are … [/font][/font]
BMJ 2014; 349 doi: http://dx.doi.org/10.1136/bmj.g7589 (Published 09 December 2014)
Cite this as: BMJ 2014;349:g7589
Owen Dyer
[font size=3]The former editor of the Journal of Patient Safety, who resigned after a US government lawsuit alleged that he had accepted substantial payments to influence national safety guidelines, also had potential conflicts of interest in nine of 10 articles he authored in his journal, a review published by the new editors has said.
Charles Denham was named in a legal settlement last December between the government and CareFusion, producer of the antiseptic skin formulation ChloraPrep. The government alleged that his company, Health Care Concepts, received $11.6m (£7.4m; €9.4m) in contracts from CareFusion and its legal predecessor Cardinal Health.1
“The United States contends that the compensation for the underlying services in these agreements was not fair market value,” the suit alleged, “and one purpose of these contracts was to conceal kickbacks to Dr Charles Denham.”
Denham was then serving as co-chair of the National Quality Forum’s Safe Practices Committee, whose safety recommendations are … [/font][/font]